These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10780327)
1. Identification of a novel 33-kDa Ser/Thr kinase that phosphorylates the cytoplasmic tail of protease-activated receptor 1 (thrombin receptor) in human platelets. Ido M; Hayashi T; Gabazza EC; Suzuki K Thromb Haemost; 2000 Apr; 83(4):617-21. PubMed ID: 10780327 [TBL] [Abstract][Full Text] [Related]
2. The thrombin receptor transmits signals through a 33-kDa protein kinase in human platelets. Ogawa H; Ido M; Takeya H; Suzuki K Biochem Biophys Res Commun; 1994 Sep; 203(2):907-13. PubMed ID: 8093074 [TBL] [Abstract][Full Text] [Related]
3. Thrombin-induced activation of the novel 33-kDa serine/threonine kinase in human platelets. Ido M; Ogawa H; Kato S; Hayashi K; Suzuki K Pol J Pharmacol; 1996; 48(1):105-7. PubMed ID: 9112637 [TBL] [Abstract][Full Text] [Related]
4. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation. Wu CC; Teng CM Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935 [TBL] [Abstract][Full Text] [Related]
6. Ca(2+)-dependent activation of the 33-kDa protein kinase transmits thrombin receptor signals in human platelets. Ido M; Kato S; Ogawa H; Hayashi K; Komada Y; Zhang XL; Sakurai M; Suzuki K Thromb Haemost; 1996 Sep; 76(3):439-43. PubMed ID: 8883283 [TBL] [Abstract][Full Text] [Related]
7. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development. Vretenbrant K; Ramström S; Bjerke M; Lindahl TL Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509 [TBL] [Abstract][Full Text] [Related]
8. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions. Bilodeau ML; Hamm HE J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299 [TBL] [Abstract][Full Text] [Related]
9. An analysis of the phosphorylation and activation of extracellular-signal-regulated protein kinase 5 (ERK5) by mitogen-activated protein kinase kinase 5 (MKK5) in vitro. Mody N; Campbell DG; Morrice N; Peggie M; Cohen P Biochem J; 2003 Jun; 372(Pt 2):567-75. PubMed ID: 12628002 [TBL] [Abstract][Full Text] [Related]
10. Amyloid beta peptide-activated signal pathways in human platelets. Shen MY; Hsiao G; Fong TH; Chen HM; Chou DS; Lin CH; Sheu JR; Hsu CY Eur J Pharmacol; 2008 Jul; 588(2-3):259-66. PubMed ID: 18511035 [TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor 4 uses anionic residues to interact with alpha-thrombin in the absence or presence of protease-activated receptor 1. Nieman MT Biochemistry; 2008 Dec; 47(50):13279-86. PubMed ID: 19053259 [TBL] [Abstract][Full Text] [Related]
13. The preparation and characterization of novel peptide antagonists to thrombin and factor VIIa and activation of protease-activated receptor 1. Nieman MT; Warnock M; Hasan AA; Mahdi F; Lucchesi BR; Brown NJ; Murphey LJ; Schmaier AH J Pharmacol Exp Ther; 2004 Nov; 311(2):492-501. PubMed ID: 15210836 [TBL] [Abstract][Full Text] [Related]
14. Newborn platelets: lower levels of protease-activated receptors cause hypoaggregability to thrombin. Schlagenhauf A; Schweintzger S; Birner-Gruenberger R; Leschnik B; Muntean W Platelets; 2010; 21(8):641-7. PubMed ID: 20807173 [TBL] [Abstract][Full Text] [Related]
15. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists. Seiler SM; Peluso M; Tuttle JG; Pryor K; Klimas C; Matsueda GR; Bernatowicz MS Mol Pharmacol; 1996 Jan; 49(1):190-7. PubMed ID: 8569706 [TBL] [Abstract][Full Text] [Related]
16. Both the high affinity thrombin receptor (GPIb-IX-V) and GPIIb/IIIa are implicated in expression of thrombin-induced platelet procoagulant activity. Dicker IB; Pedicord DL; Seiffert DA; Jamieson GA; Greco NJ Thromb Haemost; 2001 Oct; 86(4):1065-9. PubMed ID: 11686325 [TBL] [Abstract][Full Text] [Related]
17. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets. Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827 [TBL] [Abstract][Full Text] [Related]
18. Mapping the interaction of bradykinin 1-5 with the exodomain of human protease activated receptor 4. Nieman MT; Pagan-Ramos E; Warnock M; Krijanovski Y; Hasan AA; Schmaier AH FEBS Lett; 2005 Jan; 579(1):25-9. PubMed ID: 15620686 [TBL] [Abstract][Full Text] [Related]
19. Regulation of postaggregation events induced by protease-activated receptor 1 ligation in human platelets: evidence of differential signaling pathways. Ramars AS; Mukhopadhyay S; Dash D Arch Biochem Biophys; 2002 Feb; 398(2):253-60. PubMed ID: 11831857 [TBL] [Abstract][Full Text] [Related]
20. Effect of aprotinin and recombinant variants on platelet protease-activated receptor 1 activation. Day JR; Haskard DO; Taylor KM; Landis RC Ann Thorac Surg; 2006 Feb; 81(2):619-24. PubMed ID: 16427862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]